In Vivo Nasal Potential Difference: Techniques and Protocols for Assessing Efficacy of Gene Transfer in Cystic Fibrosis

Human Gene Therapy

Volumn 6, Issue 4, 1995, Pages 445-455

  Knowles, M R ^a   Paradiso, A M ^a   Boucher, R C ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE ION; COMPLEMENTARY DNA; CYCLIC AMP; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYSTIC FIBROSIS; DEATH; ELECTROLYTE TRANSPORT; FEMALE; GENE MUTATION; GENE THERAPY; GENE TRANSFER; HUMAN; ION TRANSPORT; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PHENOTYPE; POTENTIAL DIFFERENCE; RESPIRATORY EPITHELIUM; SODIUM TRANSPORT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMILORIDE; BIOLOGICAL TRANSPORT; CALCIUM; CHILD; CHILD, PRESCHOOL; CHLORIDES; COMPARATIVE STUDY; CYCLIC AMP; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTROPHYSIOLOGY; EPITHELIUM; FEMALE; GENE THERAPY; GENOTYPE; HUMAN; INFANT; INTRACELLULAR FLUID; ION CHANNEL GATING; ISOPROTERENOL; MALE; MEMBRANE PROTEINS; MIDDLE AGE; NASAL MUCOSA; NASAL POLYPS; PERFUSION; POTENTIOMETRY; SIGNAL TRANSDUCTION; SODIUM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028991826     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.1995.6.4-445     Document Type: Article

References (54)

1. ALTON, E.W.F.W., CURRIE, D., LOGAN-SINCLAIR, R., WARNER, J.O., HODSON, M.E., and GEODES, D.M. (1990). Nasal potential difference: A clinical diagnostic test for cystic fibrosis. Eur. Respir. J. 3, 922-926.
2. ALTON, E.W.F.W., MIDDLETON, P.O., CAPLEN, N.J., SMITH, S.N., STEEL, D.M., MUNKONGE, P.M., JEFFREY, P.K., GED-DES, D M., HART, S.L., WILLIAMSON, R., FOSOLD, K.I., MILLER, A.D., DICKINSON, P., STEVENSON, B.J., MCLACHLAN, G., DORIN, J.R., and PORTEOUS D.J. (1993). Non-invasive liposome-inediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat. Genet. 5, 135-142.
3. ANDERSON, M.P., GREGORY, R.J., THOMPSON, S., SOUZA, D.W., PAUL, S., MULLIGAN, R.C., SMITH, A.E., and WELSH, M.J. (1991). Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253, 202-205.
4. ANON. (1994). Gene therapy for cystic fibrosis using a replication deficient recombinant adenovirus vector to deliver the human cystic fibrosis transmembrane conductance regulator cDNA to the airways. A Phase I study. Hum. Gene. Ther. 5, 1019-1057.
5. BEAR, C.E., LI, C., KARTNER, N., BRIDGES, R.J., JENSEN, T.J., RAMJEESINGH, M., and RIORDAN, J.R. (1992). Purification and functional reconstitution of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). Cell 68, 809-818.
6. BOAT, T.F., WELSH, M.J., and BEAUDET, A.L. (1989). Cystic fibrosis. In The Metabolic Basis of Inherited Disease, 6th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, etal., eds. (McGraw-Hill Information Services Company, New York) pp. 2649-2680.
7. BOUCHER, R.C. (1994a). Human airway ion transport (Part 1). Am. J. Respir. Crit. Care. Med. 150, 271-281.
8. BOUCHER, R.C. (1994b). Human airway ion transport (Part 2). Am. J. Respir. Crit. Care. Med. 150, 581-593.
9. BOUCHER, R.C., STUTTS, M.J., KNOWLES, M.R., CANTLEY, L., and GATZY, J.T. (1986). Na”- transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J. Clin. Invest. 78, 1245-1252.
10. BOUCHER, R.C., COTTON, C.U., GATZY, J.T., KNOWLES, M.R., and YANKASKAS, J.R. (1988). Evidence for reduced Cl” and increased Na”- permeability in cystic fibrosis human primary cell cultures. J. Physiol. 405, 77-103.
11. BOUCHER, R.C., CHENG, E.H.C., PARADISO, A.M., STUTTS, M.J., KNOWLES, M.R., and EARP, H.S. (1989). Chloride secretory response of cystic fibrosis human airway epithelia: Preservation of calcium but not protein kinase C- and A-dependent mechanisms. J. Clin. Invest. 84, 1424-1431.
12. BOUCHER, R.C., KNOWLES, M.R., JOHNSON, L.G., OLSEN, J.C., PICKLES, R., WILSON, J.M., ENGELHARDT, J., YANG, Y., and GROSSMAN, M. (1994). Clinical Protocol. Gene therapy for cystic fibrosis using El-deleted adenovirus: A Phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill. Hum. Gene Ther. 5,615-639.
13. CLARKE, L.L., PARADISO, A.M., and BOUCHER, R.C. (1992). Histamine-induced Cl“ secretion in human nasal epithelium: responses of apical and basolateral membranes. Am. J. Physiol. 263, 1190-1199.
14. CLARKE, L.L., GRUBB, B.R., YANKASKAS, J.R., COTTON, C.U., MCKENZIE, A., and BOUCHER, R.C. (1994). Relationship of a non-CFTR mediated chloride conductance to organ-level disease in cftr(-/-) mice. I-oc. Natl. Acad. Sci. USA 91, 479-483.
15. COLLINS, F.S. (1992). Cystic fibrosis: Molecular biology and therapeutic implications. Science 256, 774-779.
16. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8, 42-51.
17. DAVIS, P.B. (1993). Pathophysiology of the lung disease in cystic fibrosis. In Cystic Fibrosis (Lung Biology in Health and Disease, Vol. 64). P.B. Davis, ed. (Marcel Dekker, Inc., New York) pp. 193-218.
18. EGAN, M., FLOTTE, T., AFIONE, S., SOLOW, R., ZEITLIN, P.L., CARTER, B.J., and GUGGINO, W.B. (1992). Defective regulation of outwardly rectifying Cl“ channels by protein kinase A corrected by insertion of CFTR. Nature 358, 581-584.
19. GABRIEL, S.E., CLARKE, L.L., BOUCHER, R.C., and STUTTS, M.J. (1993). CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship. Nature 363, 263-268.
20. GRUBB, B.R., PICKLES, R.J., YE, H., YANKASKAS, J.R., VICK, R.N., ENGELHARDT, J.F., WILSON, J.M., JOHNSON, L.G., and BOUCHER, R.C. (1994a). Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371, 802-806.
21. GRUBB, B.R., VICK, R.N., and BOUCHER, R.C. (1994b). Hyperabsorption of Na- and raised Ca-'-mediated Cl“ secretion in nasal epithelia of CF mice. Am. J. Physiol. 266, C1478-C1483.
22. HENDERSON, F.W., DUBOVI, E.J., HARDER, S., SEAL, E.J., and GRAHAM, D. (1988). Experimental rhinovirus infection in human volunteers exposed to ozone. Am. Rev. Respir. Dis. 137, 1124-1128.
23. HYDE, S.C., GILL, D.R., HIGGINS, C F., TREZISE, A.E.O., MACVINISH, L.J., CUTHBERT, A.W., RATCLIFF, R., EVANS, M.J., and COLLEDGE, W.H. (1993). Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 362, 250-255.
24. JOHNSON, L.G., OLSEN, J.C., SARKADI, B., MOORE, K.L., SWANSTROM, R., and BOUCHER, R.C. (1992). Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat. Genet. 2, 21-25.
25. JOHNSON, L.G., BOYLES, S.E., WILSON, J., and BOUCHER, R.C. (1994). Correction of raised Na”- absorption and raised Ca-”-mediated Cl-secretion by adenovirus-mediated expression of CFTR in primary human cystic fibrosis airway epithelial cells. Pediatr. Pulmonol. Suppl. 10, 228 (abstract).
26. KEREM, B., ROMMENS, J.M., BUCHANAN, J.A., MARK-IEWICZ, D., COX, T.K., CHAKRAVARTI, A., BUCHWALD, M., and TSUI, L. (1989). Identification of the cystic fibrosis gene: Genetic analysis. Science 245, 1073-1080.
27. KNOWLES, M., GATZY, J., and BOUCHER, R. (1983a). Modulation of nasal epithelium ion permeability in normal and cystic fibrosis subjects in vivo. Clin. Res. 31, 858A (abstract).
28. KNOWLES, M., GATZY, J., and BOUCHER, R. (1983b). Relative ion permeability of normal and cystic fibrosis nasal epithelium. J. Clin. Invest. 71, 1410-1417.
29. KNOWLES, M., MURRAY, G., SHALLAL, J., ASKIN, F., RANGA, V., GATZY, J., and BOUCHER, R. (1984). Bioelectric properties and ion flow across excised human bronchi. J. Appi. Physiol. 56, 868-877.
30. KNOWLES, M., CHURCH, N, and BOUCHER, R. (1990). Bradykinin (BK) and adenosine triphosphate (ATP) activate nasal epithelial Cl“ permselectivity in normal and CF subjects. Pediatr. Pulmonol. Suppl. 5, 221 (abstract).
31. KNOWLES, M.R., CARSON, J.L., COLLIER, A.M., GATZY, J.T., and BOUCHER, R.C. (1981a). Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo. Am. Rev. Respir. Dis. 124, 484-490.
32. KNOWLES, M.R., GATZY, J., and BOUCHER, R. (1981b). Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 305, 1489-1495.
33. KNOWLES, M.R., CLARKE, L.L., and BOUCHER, R.C. (1991). Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N. Engl. J. Med. 325, 533-538.
34. KNOWLES, M.R., CLARKE, L.L., and BOUCHER, R.C. (1992). Extracellular ATP and UTP induce chloride secretion in nasal epithelia of CF patients and normal subjects in vivo. Chest 101 (suppl), 60S-63S.
35. MIDDLETON, P.G., CAPLEN, N.J., GAO, X., HUANG, L., GAYA, H., GEODES, D.M., and ALTON, E.W. (1994). Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth. Eur. Respir. J. 7, 442-445.
36. NACLERIO, R.M., PROUD, D., LICHTENSTEIN, L.M., KAGEY-SOBOTKA, A., HENDLEY, J.O., SORRENTINO, J., and GWALTNEY, J.M. (1988). Kinins are generated during experimental rhinovirus colds. J. Infect. Dis. 157, 133-142.
37. O'NEAL, W.K., and BEAUDET, A.L. (1994). Somatic gene therapy for cystic fibrosis. Hum. Mol. Genet. 3, 1497-1502.
38. PARADISO, A.M., CHENG, E.H.C., and BOUCHER, R.C. (1991). Effects of bradykinin on intracellular calcium regulation in human ciliated airway epithelium. Am. J. Physiol. 261, L63-L69.
39. QUINTON, P.M. (1990). Cystic fibrosis: A disease in electrolyte transport. FASEB. J. 4, 2709-2717.
40. RIORDAN, J.R., ROMMENS, J.M., KEREM, B., ALON, N., ROZMAHEL, R., GRZELCZAK, Z., ZIELENSKI, J., LOK, S., PLAVSIC, N., CHOU, J., DRUM, M.L., lANNUZZI, M.C., COLLINS, F.S., and TSUI, L.-C. (1989). Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245, 1066-1073.
41. ROMMENS, J.M., lANNUZZI, M.C., KEREM, B., DRUMM, M.L., MELMER, G., DEAN, M., ROZMAHEL, R., COLE, J.L., KENNEDY, D., HIDAKA, N., ZSIGA, M., BUCHWALD, M., RIORDAN, J.R., TSUI, L.-C., and COLLINS, F.S. (1989). Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245, 1059-1065.
42. SAUDER, R.A., CHESROWN, S.E., and LOUGHLIN, G.M. (1987). Clinical application of transepitheUal potential difference measurements in cystic fibrosis. J. Pediatr. Ill, 353-358.
43. SORSCHER, E.J., LOGAN, J.J., FRIZZELL, R.A., LYRENE, R.K., BEBOK, Z., DONG, J.Y., DUVALL, M.D., FELGNER, P.L., MATALON, S., WALKER, L., and WIATRAK, B.J. (1994). Clinical Protocol. Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer. A Phase I trial of safety and efficacy in the nasal airway. Hum. Gene Ther. 5, 1259-1277.
44. STUTTS, M.J., GATZY, J.T., and BOUCHER, R.C. (1988). Effects of metabolic inhibition on ion transport by dog bronchial epithelium. J. Appl. Physiol. 64, 253-258.
45. STUTTS, M.J., KNOWLES, M.R., CHINET, T., and BOUCHER, R.C. (1991). Abnormal ion transport in cystic fibrosis airway epithelium. In The Airway Epithelium. Physiology, Pathophysiology, and Pharmacology. S.G. Farmer and D.W.P. Hay, eds. (Marcel Dekker, Inc. New York) pp. 301-334.
46. WALTNER, W.E., BOUCHER, R.C., GATZY, J.T., and KNOWLES, M.R. (1987). Pharmacotherapy of airway disease in cystic fibrosis. Trends. Pharmacol. Sci. 8, 316-320.
47. WELSH, M.J. (1990). Abnormal regulation of ion channels in cystic fibrosis epithelia. FASEB. J. 4, 2718-2725.
48. WILLUMSEN, N.J., and BOUCHER, R.C. (1989). Activation of an apical Cl-conductance by Ca-”- ionophores in cystic fibrosis airway epithelia. Am. J. Physiol. 256, C226-C233.
49. WILLUMSEN, N.J., and BOUCHER, R.C. (1991a). Sodiumti-ansport and intracellular sodium activity in cultured human nasal epithelium. Am. J. Physiol. 261, C319-C331.
50. WILLUMSEN, N.J., and BOUCHER, R.C. (1991b). Transcellular sodium transport in cultured cystic fibrosis human nasal epithelium. Am. J. Physiol. 261, C332-C341.
51. WILSON, J.M., ENGELHARDT, J.F., GROSSMAN, M., SIMON, R.H., and YANG, Y. (1994). Gene therapy of cystic fibrosis lung disease using El deleted adenoviruses: A phase I trial. Hum. Gene Ther. 5,501-519.
52. WILSON, R., ALTON, E., RUTMAN, A., HIGGINS, P., AL-NA-KIB, W., GEDDES, D.M., TYRRELL, D.A., and COLE, P.J. (1987). Upper respiratory tract viral infection and mucociliary clearance. Eur. J. Respir. Dis. 70, 272-279.
53. WU, R., YANKASKAS, J., CHENG, E., KNOWLES, M.R., and BOUCHER, R. (1985). Growth and differentiation of human nasal epithelial cells in culture. Serum-free, hormone-supplemented medium and proteoglycan synthesis. Am. Rev. Respir. Dis. 132, 311-320.
54. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transientiy corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.